Mercalis’ Post

The patient access landscape continues to evolve: top of mind are public policy impacts like the Inflation Reduction Act (IRA) and rapid advancements in technology, especially AI. Our team is well equipped to guide manufacturers through policy changes and we stand at the ready to leverage our expertise to meet the evolving needs of patients and providers. #PatientAccess #HealthcarePolicy #AI #Technology #HealthcareProviders https://lnkd.in/eq_6Rh7d

I continue to be blown away by the magnitude of the impact that Gen AI can have on long-established processes. This is a great article on how Syneos Health and BCG X worked together to shorten the time to developing the protocol for a clinical trial from months to days by leveraging #GenAI. Even more important than being able to shorten that start-up time for the trial, the process still ensures multiple checks for safety and quality control. My favorite line from the article describes the process as, “one where human expertise is unlocked by AI, and AI’s awesome analytical power is tempered by human discernment.” https://lnkd.in/emdEY9tH

There is a vital need to involve physicians, build #trust in real-world evidence (#RWE), and promote collaboration among stakeholders for improved #patient care and research #efficacy. Read this free Reuters Events article today. Reuters Events Pharma There are many opportunities in getting the attention of physicians by applying algorithms to real word data, for example from #EMRs, for modeling purposes. The models might show the results for patients if they received alternative treatments or no treatment at all. Biopharma should further calibrate #clinicaltrials to reflect the real world for patients and physicians. “How can we deploy #tokenization to have a seamless transition from the trial into the real world? That experience can be captured in a way that extends the external #validity, #generalizability, and #transportability of these trial results,” Lott says. https://lnkd.in/egQyJMhZ Reuters Events #realworlddata #realworldevidence #outcomes #patientjourney #patientcentricity #patientexperience #AI #bigdata

Have you considered how AI can be used in the drug development process? My colleague BARADWAJ S. has written an amazing piece on using AI for patient enrolment. Let's talk about your thoughts on this... #ai #artificialintelligence #patientenrolment #drugdevelopment Read the article here: https://lnkd.in/eUfA5PMA

Our Biovista AI Health Shield is finally here! https://lnkd.in/eh89dffe For a few years now, we have used our #AI in #healthcare mode to help patients or doctors who would ask us for unbiased and "no stone unturned" ideas about the multiple drugs they are taking, their side effects etc. It is now time to properly assemble this as a #personalizedmedicine service. THANK YOU to the patients and doctors who came to us to get this rolling, and are unsatisfied with "Dr. Search Engine" or language models and the like. THANK YOU to the Biovista team for making this possible. If you or someone you care about are on this #health journey, the AI Health Shield was designed for you: 1. Frequent visits to different doctors; 2. Taking all sorts of drugs; 3. Hoping different doctor offices share updated medical information;  4. Despite it all, keep feeling sick; 5. Unsure what to do next other than more of the same; 6. OR: doing great, thank you, but just need an unbiased credible health data tech in your corner for when needed; 7 OR: I’m a doctor, not afraid to ask questions and consider credible alternative ideas.

Learn more about the first key benefit of real-world data (#RWD) in Elizabeth Smalley's article: https://lnkd.in/eWQvrcwP #artificialintelligence #AI #automation #patientsafety

Can you really have too much of a good thing? Where is the tipping point for technology in a clinical trial? 6 different systems and logins? How about 12? An interesting article on the need for connected technologies to reduce site burden. #Technology #AI #ClinicalTrialManagement #LifeSciencesTranslationExperts

"Personalized medicine will be a focus Using advanced analytics, machine learning, and computational power to glean insights from data, clinical research will continue to focus on ways to create personalized therapies for individuals’ exact conditions, not just general diseases. We expect to see a significant shift towards embracing the patient’s voice and ensuring that every stage in drug development is informed by the nuanced, real-life experiences of diverse patient populations. Advances in technology, particularly generative AI, and high-performance cloud computing, can now enable us to analyze vast and varied datasets with unprecedented speed and precision." #pharma #AI #MachineLearning

🎉Congratulations to AllazoHealth for their recognition on the PM360 Magazine 2023 Innovator List! We’ve seen firsthand how their innovative work in AI optimizes patient outcomes and pushes boundaries in healthcare, and we can’t wait to see what 2024 holds for them. 🚀 Learn more about the incredibly important work they’re doing: https://lnkd.in/eqM3QpV4 #HealthcareInnovation #AI #HealthcareAI

Experts predict that, in the next several years, #AI could radically transform the healthcare sector, alleviating time pressures and improving doctor-patient relationships. 🤝 Business Insider spoke with ArteraAI's own Tim Showalter, Chief Medical Officer, about the power of AI in #precisionmedicine, and how technology like the ArteraAI #Prostate Test can "aid doctors in making #personalizedtreatment decisions":